ADPKD患者肝囊肿感染的治疗结局分析
该多中心回顾性研究纳入62例ADPKD患者的112次肝囊肿感染发作,发现治疗失败或复发 occurred in 27%,复发在38%患者中出现且24%在1年内。抗生素疗程≥14天降低治疗失败/复发风险,≥28天降低复发风险,而肾囊肿感染史增加1年内复发风险。
要点
- 抗生素疗程≥14天与较低治疗失败/复发风险相关(OR=0.03)。
- 抗生素疗程≥28天与较低复发风险相关(OR=0.12)。
- 肾囊肿感染史显著增加1年内复发风险(OR=9.22)。
核心结论
- 肝囊肿感染治疗失败或复发/再发在约三分之一病例中发生,与抗生素疗程<28天相关。
研究设计与样本
- 多中心回顾性研究,纳入62例ADPKD患者共112次肝囊肿感染发作。
- 肝囊肿感染定义基于CRP≥50 mg/l且影像学怀疑或囊肿穿刺证实。
主要发现
- 112次发作中70次(63%)检出病原体,其中大肠埃希菌占36/70(51%)。
- 大肠埃希菌对三代头孢、氟喹诺酮、复方磺胺甲噁唑耐药率分别为13%、16%、34%。
- 治疗失败和复发共30/112次(27%)。
- 复发在24/62例(38%)患者中出现,其中15例(24%)在首次发作后1年内复发。
关键数值与推荐
- 抗生素疗程≥14天是治疗失败或复发的保护因素(OR=0.03,95%CI 0-0.23,P=0.006)。
- 抗生素疗程≥28天是复发的保护因素(OR=0.12,95%CI 0.02-0.65,P=0.021)。
- 肾囊肿感染史增加1年内复发风险(OR=9.22,95%CI 1.28-99.55,P=0.04)。
临床怎么用
- 对ADPKD肝囊肿感染患者,应考虑足够长的抗生素疗程(≥14天以减少失败/复发,≥28天以减少复发)。
- 有肾囊肿感染史的患者需警惕1年内复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Liver cyst infection is a rare and severe complication of the liver cysts associated with autosomal dominant polycystic kidney disease (ADPKD), and evidence-based data for optimal management is lacking. We conducted a multicentric retrospective study to investigate the treatment and outcomes of liver cyst infection. METHODS: Liver cyst infection was either defined by (i) C-reactive protein levels ≥ 50 mg/l and suspicion at computed tomography (CT) scan, 18Fluorodeoxyglucose (18FDG) positron-emission tomography (PET) CT, magnetic resonance imaging (MRI); or (ii) proven by cyst puncture. We studied the determinants of treatment failure (persistent infection with requirement for antibiotic therapy change, cyst drainage, and hepatectomy), relapse (< 2 months) and recurrence (> 2 months) of liver cyst infection after antibiotics discontinuation. RESULTS: Sixty-two patients and 112 episodes were included. At least 1 microorganism was identified in 70 of 112 episodes (63%), mainly Escherichia coli in 36 of 70of cases (51%). E coli was resistant to third generation cephalosporin, fluoroquinolone, or cotrimoxazole in 13%, 16%, and 34%, respectively. Treatment failure and relapse occurred in 30 of 112 episodes (27%). Antibiotic therapy duration ≥ 14 days was a protective factor for treatment failure or relapses (odds ratio [OR] = 0.03, 95% confidence interval [CI]: 0-0.23], P = 0.006). Recurrence occurred in 24 of 62 patients (38%), within 1 year for 15 patients (24%) after the first episode. An antibiotic therapy duration ≥ 28 days was identified as a protective factor (OR = 0.12, 95% CI: 0.02-0.65], P = 0.021). Conversely, a history of renal cyst infection significantly increased the risk of recurrence within 1 year (OR = 9.22 95% CI: 1.28-99.55], P = 0.04). CONCLUSION: Treatment failure or relapse or recurrence of liver cyst infection both occurred in one-third of cases, and are associated with a shorter antibiotic therapy duration < 28 days.
引用
- Ronsin C, Jouret F, Ville S, et al. Liver Cyst Infection Outcomes in Patients With ADPKD. Kidney Int Rep. 2025. PMID: 41541773. doi:10.1016/j.ekir.2025.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。